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The t(14;18)(q32;q21) translocation results 
from a mistake of V(D)J recombination and 
juxtaposes the BCL2 protooncogene with the 
nonexpressed immunoglobulin heavy chain 
(IGH) allele (1). As a consequence, the BCL2 
gene comes under the control of the IGH 
  enhancer, causing deregulated expression of 
the antiapoptotic BCL2 protein. Although 
t(14;18) and ectopic BCL2 expression consti-
tute the initial events of follicular lymphoma 
(FL) pathogenesis, further B cell diff  erentiation 
and additional events are clearly required 
for malignant transformation (2–4). However, 
early steps of disease progression are still un-
clear. The presence of the translocation in pe-
ripheral blood from healthy individuals (HI) 
at an average rate of 0,1–10 cell every million 
(5–7) led to the hypothesis that t(14;18) is car-
ried by resting naive B cells. In such cells, 
BCL2 oncogenic potential would be restrained, 
partly because of the fact that they express 
BCL2 physiologically. Intriguingly, we re-
cently reported that in absence of manifest 
clinical lymphoma, clonotypic t(14;18)+ cells 
can persist over a 3-yr period in the peripheral 
blood from HI (8). As peripheral blood con-
tains a mixture of naive and memory B cells, 
this unexpected fi  nding led us to question the 
current model of FL pathogenesis and charac-
terize further such long-lived t(14;18)+ clones.
RESULTS AND DISCUSSION
As a fi  rst approach, we sought to determine if 
t(14;18)+ cells in HI are indeed naive B cells 
by assessing their class-switch recombination 
(CSR) status. CSR is a hallmark of the germi-
nal center (GC) reaction and is absent in naive 
cells. To characterize rare t(14;18)+ cells out of 
the bulk of normal cells, we took advantage of 
their unique BCL2/IGH translocation signa-
ture. Indeed, the BCL2/JH fusion does not 
  prevent CSR occurring on the downstream 
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Follicular lymphoma is one of the most common adult lymphoma, and remains virtually 
incurable despite its relatively indolent nature. t(14;18)(q32;q21) translocation, the ge-
netic hallmark and early initiating event of follicular lymphoma (FL) pathogenesis, is also 
present at low frequency in the peripheral blood of healthy individuals. It has long been 
assumed that in healthy individuals t(14;18) is carried by circulating quiescent naive 
B cells, where its oncogenic potential would be restrained. Here, we question this current 
view and demonstrate that in healthy individuals, t(14;18) is actually carried by an ex-
panding population of atypical B cells issued from germinal centers, displaying genotypic 
and phenotypic features of FL, and prone to constitute potent premalignant FL niches. 
These fi  ndings strongly impact both on the current understanding of disease progression 
and on the proper handling of t(14;18) frequency in blood as a potential early biomarker 
for lymphoma.
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constant region of the IGH locus (9, 10), and frequency 
above 10−5 (Table I, BCL2/JH) were selected from our pre-
vious cohort of HI (8), and two separate LR-PCR reactions 
were conducted: one designed to amplify the unswitched 
BCL2/Sμ region, and the other to amplify switched BCL2/
Sγ regions (Fig.1). Results show that only two out of six in-
dividuals were found positive for BCL2/Sμ, whereas fi  ve out 
of six were positive for BCL2/Sγ (Fig. 1 C, left, and Table I). 
Accordingly, individual and cumulative ratios of amplicons 
were signifi  cantly higher for BCL2/Sγ (9:50) than for BCL2/
Sμ (2:55) (P = 0.02). In addition, identical BCL2/JH junc-
tion signatures were found between BCL2/JH and BCL2/Sγ 
amplicons, but not with BCL2/Sμ amplicons (Table I, aster-
isks), indicating that most translocations previously detected 
in the blood of HI (5–8) are actually switched. Furthermore, 
clonal fi  liations between switched and unswitched cells were 
found in one sample (#102), supporting the presence of an 
active CSR process in the t(14;18)+ clones. Altogether, and 
contrary to previous assumptions, these data clearly show that 
most peripheral t(14;18)+ cells already underwent CSR, and 
therefore such cells are not naive B cells.
We next assessed if these long-lived t(14;18)-bearing B 
cells in HI already transited through the GCs. Circulating na-
ive and memory B cells can be distinguished on the basis of 
the CD27 cell surface marker and sIg isotypes (11–13). Fresh 
PBMCs from 10 healthy donors were collected, and IgD+/
CD27− naive, IgD+/CD27+ memory, and IgD−/CD27+ 
switched memory B cell subsets isolated by cell sorting (Fig. 
2 A). The occurrence of t(14;18) was then assessed in total 
PBMCs and in each fraction by the short-range BCL2/JH 
Figure 1.  Most t(14;18) translocations in HI are associated with 
CSR. The translocation region (here with a mbr/JH6 breakpoint) on the 
der(14) chromosome is depicted with either an unswitched (A) or a 
switched (B) confi  guration. PCR primers are indicated. Reverse 3′C/Sγ 
primers are consensus for the 4 γ isotypic subclass regions (Cγ1-4/S γ1-4). 
The sizes of the BCL2/Sμ amplicons are expected to range from 7.5 
to 8 kb, depending on BCL2 breakpoints. As CSR is imprecise and can 
occur anywhere in the  3 kb Sμ and Sγ recombination sites (29), 
BCL2/Sγ amplicon sizes are expected to range from 4 to 11 kb. N, N 
nucleotides present in the BCL2/JH junction; ovals, switch regions up-
stream of each constant region (except Cδ). (C) BCL2/Sμ (top) and 
BCL2/Sγ (bottom) LR-PCR from two of the six HI (#127, #103; left) and 
from 8 of the 30 FL patients (right) are shown. 23 out of 30 FL samples 
underwent CSR to Cγ (not depicted). Given the low t(14;18) frequency 
level in HI, a two-step fl  uctuation nested LR-PCR assay was used, con-
sisting of at least fi  ve parallel replicates per sample (left, lanes 1–5). In 
the fl  uctuation range, at most one target molecule is present per PCR 
replicate, and if so will give rise to a detectable amplicon. The ratio of 
positive versus negative replicates allows the estimation of the fre-
quency of the target. A standard single round LR-PCR was used for the 
FL samples (right). The t(14;18)+ RL7 cell line harbors a Sγ1-associated 
BCL2/JH6 der(14), and was used as positive control for the BCL2/Sγ 
amplifi  cation (C+) and as negative control for the BCL2/Sμ (C−); PCR 
amplifi  cations of the β-globin gene (β-glob, 7.5 kb) and of a Dβ1-
Jβ2.7 germline fragment of the human TCR-β locus (TCR-β, 11.5 kb) 
were performed on each sample as controls for LR-PCR. In case #127, 
BCL2/Sγ amplifi  cation gave rise to two different sizes of amplicons. 
Cloning/sequencing revealed that the two amplicons corresponded to 
two distinct translocations, indicating the presence of oligo/polyclonality 
in the switched population. In FL, the differences in PCR intensities are 
related to the individual t(14;18) frequency, the origin (lymph node, 
bone marrow, PBMCs), and the conditioning (e.g., paraffi  n) of the 
  particular samples (28). All positive PCR products were confi  rmed by 
cloning/sequencing (unpublished data).JEM VOL. 203, October 30, 2006  2427
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PCR assay (Fig. 2 B and Table II). As a fi  rst approach, we 
pooled data from the two CD27+ memory subsets and exam-
ined the overall contribution of naive (CD27−) and memory 
(CD27+) B cells to the total t(14;18)+ frequency calculated as 
a fraction of CD19+ B cells (Fig. 2 C). t(14;18) frequencies of 
CD19+ B cells ranged from <1/105 to the unexpectedly high 
rate of  1/3.500 B cells in some individuals (Fig. 2 C, squares). 
Strikingly, although the level of naive t(14;18)+ cells con-
stantly remained at baseline (Fig. 2 C, circles), CD27+ B cells 
accounted in a large part for the amplitude of t(14;18) fre-
quencies (Fig. 2 C, triangles). This clearly indicates that circu-
lating t(14;18)+ clones in HI are indeed predominantly B cells 
which transited through the GCs. To determine if the pres-
ence of high levels of t(14;18) in some individuals was caused 
by a higher incidence of   distinct translocations or to the clonal 
expansion of a given t(14;18)+ B cell, we cloned and se-
quenced 55 out of 61 BCL2/JH fragments from the CD27+ 
subset. One major BCL2/JH junction was observed in most 
individuals (Fig. 2 D, black bars), indicating that only one 
clone mainly accounted for t(14;18) frequencies. Remarkably, 
this data demonstrate that the wide modulation of t(14;18) 
frequency in HI is not caused by the accumulation of clonally 
unrelated t(14;18) naive B cells in some individuals, but rather 
to the clonal expansion in the GCs of t(14;18)+ B cells.
To defi  ne further the t(14;18)+ cells, we next examined 
the repartition of the translocation in the two memory B cell 
subsets: the IgD−/CD27+ switched memory and the IgD+/
CD27+ so-called “IgM memory” (Table II) (11–14). Un-
expectedly, the IgD+/CD27+ subset contained signifi  cantly 
higher rates of translocation, both in terms of prevalence 
(nine out of nine samples versus six out of nine, P = 0.05) 
and frequency (35 versus 14%, P = 0.001). This predomi-
nance of a surface IgD/M and not IgG in t(14;18)+ cells was 
in apparent contradiction with our previous LR-PCR results, 
in which switch to Cγ was prevalent on the translocated al-
lele (Table I). To investigate reasons underlying this paradox, 
we performed the BCL2/Sμ and BCL2/Sγ LR-PCR assays 
on the fractionated cells from four healthy donor samples 
(Fig. 2 E). As expected, CSR happened on both alleles in 
the IgD−/CD27+ subset (Fig. 2 F). More surprisingly, CSR 
also frequently occurred on the translocated allele in the pre-
dominant IgD+/CD27+ subset. This is in sharp contrast with
the features of the peripheral IgD+CD27+ IgM memory 
B cell subset, which is entirely devoid of CSR both on the 
productive and the nonproductive alleles (Fig. S1, available at 
http://www.jem.org/cgi/content/full/jem.20061292/DC1) 
(12, 13). It is therefore very likely that the t(14;18)+ cells are 
distinct from this subset, albeit superimposed on the basis of 
the CD27 and IgD markers. Most importantly, the presence 
of CSR on the nonfunctional, but not on the productive 
allele is atypical among normal circulating memory B cells. 
However, this “allelic paradox” stands as a hallmark of FL 
(9, 10). FL derives from follicle center B cells that encountered 
antigen and are undergoing somatic hypermutation and CSR 
(1, 15). In FL, CSR occurs as frequently on both alleles, but 
“downstream switch” (e.g., Sγ-to-Sα) happens at unusually 
high frequency on the productive allele, specifi  cally sparing 
the Cμ region from deletion and allowing sIgM/D expres-
sion (9). Consequently, despite CSR occurring on both al-
leles in >80% of cases, most FL cases still express a sIgM and 
only a minority expresses sIgG, sIgA, or no sIg (Fig. 1 C) 
(9, 10, 16). This allelic paradox indicates the presence of a se-
lective pressure in favor of sIgM expression on a B cell popula-
tion that is at the same time permanently driven to switch (9). 
Together with the presence of sIgM+ B cell follicular hyper-
plasia in BCL2 transgenic mice (2, 4), this atypical feature 
of t(14;18)+ cells both in FL and HI suggests a direct role of 
BCL2 ectopic expression in the GCs for this selection. Data 
from BCL2-Tg mice indicate that long-term survival of fol-
licular B lymphocytes in the GC is of key importance for the 
acquisition of further genetic changes, which in turn favor 
further cell transformation and progression to disease (17). It 
is likely that in HI most t(14;18)+ cells were similarly rescued 
by BCL2 from apoptosis and “frozen” at a diff  erentiation 
stage in which constitutive activation-induced cytidine de-
aminase expression drives continuous somatic hypermutation 
Table I.  Analysis of CSR on the t(14;18)+ translocated allele in peripheral blood from HI
Sample BCL2/JH
a BCL2/Sμ BCL2/Sγ
Detection Ratio Frequency Detection Ratio Associated  JH Detection Ratio Associated JH Isotype
  99 yes 11:30 1.1 × 10−5 no 0:10 - yes 1:5 JH6* γ1
102 yes 23:30 3.6 × 10−5 yes 1:5 JH5 yes 1:5 JH5 γ1
103 yes 14:30 1.6 × 10−5 yes 1:10 JH6b no 0:10 - -
109 yes 12:30 1.3 × 10−5 no 0:10 - yes 1:10 JH? γ2
120 yes 11:30 1.1 × 10−5 no 0:10 - yes 2:10 JH4* γ1
127 yes 23:30 3.6 × 10−5 no 0:10 - yes 4:10 JH6* γ2
JH6* γ1
Mean 2.1 × 10−5
Total 6:6 2:6 2:55b 5:6 9:50b
aPreviously described in reference 8 Ratio, positive replicates:total replicates.
bCumulative occurrence of BCL2/Sμ junctions, as determined by the Pearson’s χ2 test, was signifi  cantly lower than BCL2/Sγ junctions (P = 0.02).
*BCL2/JH junction identical to the one previously found with the BCL2/JH PCR assay (8).2428  FOLLICULAR LYMPHOMA-LIKE B CELLS IN HEALTHY INDIVIDUALS | Roulland et al. 
Figure 2.  t(14;18)+ B cells in the peripheral blood of HI are not 
naive B cells and constitute an expanding population of FL-like 
clones. (A) Human PBMCs from 10 consecutive blood samples were 
collected from anonymous healthy donors, and IgD+/CD27− naive, IgD+/
CD27+ memory, and IgD−/CD27+ switched memory B cell populations 
were isolated by cell sorting. Results from a representative cell-sorting 
experiment are shown. (B) Genomic DNA from the three purifi  ed subsets 
was tested for the presence of t(14;18) using the short-range BCL2/JH 
PCR assay (mbr20A/21A and JHcoB/cointB nested primers; see Fig. 1 A). 
A two-step “fl  uctuation” nested PCR assay was used, consisting of at least JEM VOL. 203, October 30, 2006  2429
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and CSR activity (18), two mechanisms conferring a high 
propensity for further oncogenic aberrations in the context 
of accumulating genomic instability (e.g., BCL6/p53) (1, 19, 
20). In this scenario, t(14;18)+ cells in HI would constitute 
much more advanced precursors of the FL pathogenesis path-
way than previously thought.
Based on our data, we propose a new model in which 
long-lived t(14;18)+ cells in peripheral blood of HI are mainly 
constituted by an atypical population of BCL2-rescued 
and incompletely maturated FL-like B cells released from 
the GCs (Fig. S2, http://www.jem.org/cgi/content/full/
jem.20061292/DC1). Interestingly, this incomplete maturation 
phenotype does not prevent FL to exit from the GC nor its 
spreading to other secondary organs, including lymph nodes 
and bone marrow (16, 21). Contrary to normal GC-derived B 
cells, FL clones are prone to intense traffi   cking between folli-
cles (3, 22). Do the similar features of FL-like cells in HI confer 
the same migration properties, and similarly to BCL2-Tg mice 
(17), allow the seeding of premalignant niches? The persistence 
and clonal expansion of t(14;18)+ follicular-like B cells over 
years in blood from HI (6, 8) goes along with the existence 
of niches, where follicular microenvironment might provide 
support for maintenance/proliferation in the context of poly-
clonal/chronic antigenic stimulation (1, 15, 23, 24). In sup-
port of this, hepatitus C virus patients, who display increased 
prevalence of t(14;18), show parallel regression of viral load 
and t(14;18) frequency in blood after antiviral therapy (25).
It remains fundamental to know if the rate of expanded 
FL-like cells in the peripheral blood of HI translates their acti-
vation status. Epidemiological studies have reported an in-
creased prevalence of the t(14;18) associated with environmental 
exposures that might contribute to lymphomagenesis (26,27). 
Further studies on the origin and status of the circulating 
FL-like B cells will thus be of prime importance, both to gain 
insights into disease progression and for the proper handling of 
t(14;18) as an early biomarker of lymphoma.
MATERIALS AND METHODS
Patients and HI samples. Human samples were derived from three 
  origins: 6 DNA samples from a cohort of HI (8), for which the presence of 
t(14;18) translocation had been previously assessed on total PBMCs (7, 8); 10 
consecutive anonymous blood samples (200–300 ml) from the local blood 
bank; 30 FL DNA samples from two independent sources previously de-
scribed (28). Samples were collected after informed consent and approval by 
the local ethical committee (CCPPRB# 99–07, France).
Antibodies. The following antibodies were used: IgD biotinylated, CD19-
APC (BD PharMingen), CD27-PE, CD20-FITC (Immunotech), and IgD-
FITC (Caltag Laboratories). Primary biotinylated antibody was revealed 
with Streptavidin–PerCP-Cy5.5 conjugate (BD PharMingen).
Cell separation and fl  ow cytometry. PBMCs were isolated from periph-
eral blood by Ficoll-Hypaque density centrifugation (BD Biosciences); 
B cells were enriched to >95% using the B cell negative isolation kit (Dynal). 
B-enriched cells were preincubated for 15 min with PBS-BSA-1%–Azide-
5% normal mouse serum and stained with either IgD biotinylated or IgD-
FITC, CD27-PE, and CD19-APC for 20 min at +4°C. After washing with 
PBS-1% BSA-Azide and 15-min incubation with Streptavidin–PercP-
Cy5.5, cells were analyzed on a FACScalibur (BD Biosciences). Cell sorting 
of (a) IgD+/CD27− naive B cells, (b) IgD+/CD27+ IgM memory B cells, 
and (c) IgD−/CD27+ switched memory B cell subsets (11) was performed 
on a FACSAria (BD Biosciences). For all individuals, IgD+CD27− and 
IgD−CD27+ B cell subsets were sorted to >98% purity, and the IgD+CD27+ 
B cell subset was sorted to >95% purity. Isolated cells were then cryopre-
served at −80°C until DNA extraction. IgM- and IgD-only cells that repre-
sent only minor components (1–3%) of the memory B cell pool were not 
sorted as single cells (11, 12).
Short-range PCR amplifi  cation of BCL2-IGH junctions. Total ge-
nomic DNA was prepared from PBMCs and/or sorted B cell subpopulations 
by the Qiagen DNA Blood Mini kit according to the manufacturer’s instruc-
tions including RNase treatment (Qiagen). A two-step double-nested fl  uctua-
tion PCR assay (8) was used to amplify BCL2/JH junctions (Fig. 1 A and Table 
S1, available at http://www.jem.org/cgi/content/full/jem.20061292/DC1, 
for mbr20A/21A and JHCo-B/Coint-B primers). As the frequency of 
t(14;18) junctions is low in PBMCs from HI, 5–10 reactions were performed 
in parallel using 100 ng of DNA (per reaction) from each isolated B cell sub-
population. In the fl  uctuation range, at most one target molecule is present 
per PCR replicate, and if so will give rise to a detectable amplicon. The de-
tection threshold of the assay is the function of the number of replicates per-
formed with a constant amount of DNA per replicate (here, 2 × 10−6 for 
100 ng). The frequency of the event can then be calculated from the number 
of positive BCL2/JH amplicons using a Poisson’s assumption (7). The pri-
mary PCR conditions were as follows: 30 s at 94°C, 30 s at 62°C, and 1 min 
at 72°C, 40 cycles. 1 μl of each primary PCR reaction was used in the nested 
secondary PCR in the same conditions, except for 20 cycles.
fi  ve parallel replicates performed for each sample (lanes 1–5). Results 
from sample #20 using 100 ng per replicate is depicted. (C) The contri-
bution of naive (CD27−, white circles) and memory (CD27+, black tri-
angles) B cells to the total t(14;18)+ frequency (CD19+, gray squares) in 
the healthy donors is shown. The translocation frequency in each subset 
was plotted for each donor (Table II). The 10 samples are ordered ac-
cording to increasing CD19+ total B cell translocation frequencies (gray 
squares). (D) PCR fragments from CD27+ memory B cells were cloned 
and sequenced, and clonality was identifi  ed on the basis of the BCL2/JH 
junction, which is unique for a given translocation. The frequency of 
each independent BCL2/JH clone was calculated, and the contribution of 
each clone (vertical bars, each color represents a given clone in a given 
sample) was superimposed on the t(14;18) frequency from the CD27+ 
subset (black triangles). All positive amplicons were sequenced except 
one in sample #12, three in #15, and two in #24 (percentage on top of 
histograms corresponds to the number of sequenced amplicons on the 
total number of positive replicates; Table II). For #99, which required 
DNA dilution for the calculation of the frequency, 100% corresponds to 
the sequencing of 10 out of 10 clones obtained from amplifi  cations 
performed on diluted DNA (1:5; Table II) and undiluted DNA (9:9; not 
depicted). (E) BCL2-Sγ (top) and BCL2/Sμ LR-PCR (bottom) were per-
formed in the 3 IgD+/CD27− naive, IgD+/CD27+ memory, and IgD−/CD27+ 
switched memory B cell subsets for four HI (#15, #20, #21, and #24). 
Results from sample #24 are shown. β-globin/TCR-β controls were 
performed as control for long-range amplifi  cations (unpublished data). 
Most positive amplicons were confi  rmed by cloning/sequencing and 
alignment to germline BCL2, Sμ, and Sγ loci (not depicted). Samples 
presenting multiple size bands revealed oligo/polyclonality. (F) The over-
all distribution of switched (gray histograms) versus unswitched (white 
histograms) translocated alleles in the three B cell subsets from samples 
#15, #20, #21, and #24 is represented. The ratio of positive replicates is 
indicated at the top of the bars.2430  FOLLICULAR LYMPHOMA-LIKE B CELLS IN HEALTHY INDIVIDUALS | Roulland et al. 
LR-PCR amplifi  cation of BCL2/C𝗍 and BCL2/C𝗄 regions. For 
the amplifi  cation of BCL2/Cμ, the mbr20A/21A pair of nested forward 
primers was used in combination with a pair of nested reverse primers 
located in the Cμ and Sμ regions, respectively (3′Cμ-1B/3′Sμ-2B). For 
the amplifi  cation of BCL2/Cγ, the same forward primers were used in 
combination with a pair of reverse nested consensus primers designed 
to hybridize to the 3′ fl   anking sequences of all Cγ and Sγ1-4 regions 
(3′CγCons-1B/3′SγCons-2B). The same fl  uctuation PCR approach as for 
the short-range PCR assay was used (100 ng/replicate). Given the clonal 
nature of the tumor cells, a one-step standard LR-PCR approach was per-
formed for FL patients. DNA extracted from all samples was controlled 
to be suitable for LR-PCR by performing the amplifi  cation of a 7.5-kb 
fragment β-globin gene and an 11-kb germline fragment of the TCR-β 
locus. The following PCR conditions were used: 3 min at 95°C, 35 cycles 
(1 min at 95°C, 12 min at 68°C) and 10 min at 68°C. 1 μl of the primary 
LR-PCR was used in the double-nested LR-PCR performed in the same 
conditions, except for 20 cycles.
Analysis of BCL2/S𝗍 and BCL2/S𝗄 clones. PCR fragments were 
  purifi  ed and cloned into the pGEM-T Easy Vector (Promega). Blunt-ended 
fragments generated by LR-PCR were purifi  ed and submitted to the A-
  tailing procedure before cloning. The resulting clones were sequenced and 
analyzed using the BLASTn shareware (http://www.ncbi.nlm.nih.gov) and 
Vector NTI 9.0.0 sequence analysis software (Informax).
Statistical analysis. p values for t(14;18)-associated switch junctions 
analysis and analysis of t(14;18)+ cell distributions in peripheral B cell com-
partments were calculated by Fisher’s exact test or chi-square test using 
STATA software (STATA corporation release 7.0). p values for t(14;18) 
  frequency were calculated by two-tailed Student’s t test.
Online supplemental material. Fig.S1 illustrates the set of LR-PCR data 
showing absence of CSR on the nonfunctional allele of the peripheral blood 
sIgM/D+CD27+ B cell subset. Fig. S2 illustrates a reappraisal of the current 
model of FL pathogenesis. Table S1 describes the sequence of the PCR 
primers. Online supplemental material is available at http://www.jem.
org/cgi/content/full/jem.20061292/DC1.
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